Azina® partnered with an expansive academic health system to gain access to a large payor network and key oncology drugs, improving financial performance and enhancing patient care.

An Academic Health System Aims to

GROW AND MAXIMIZE THEIR SUCCESS

An established specialty pharmacy within a large academic hospital system turned to Azina for guidance to access payor networks, which would exponentially increase the prescriptions available to their patients. And by integrating those scripts into clinical processes, the hospital system would also realize substantial revenues.

The hospital system also leaned into Azina’s expertise to access a limited distribution oncology drug network to support their large cancer center. This would be a game-changer both clinically and financially.

Azina implemented a growth strategy focused on these goals, empowering the client to maximize success.

Azina's GROWTH STRATEGY

Staffing:

Azina built an enhanced staffing plan for the client, supporting recruitment of leading experts and professionals to lead the specialty pharmacy. Our experts put the right candidates in strategic roles to streamline operations and strengthen performance.

Accreditation:

Azina leveraged the client’s dual accreditation to demonstrate their quality patient care, expert personnel, effective policies, and advanced technology. This created a baseline level of trust that enabled them to conduct business fluidly with any industry stakeholders.

Drug Manufacturers:

Azina leveraged hospital and pharmacy performance to reach manufacturers, develop trust, and gain access to limited distribution drugs. This included documentation on the specialty pharmacy’s proven clinical expertise, financial reporting technology, operational and clinical outcomes, medication handling, and yes, dual accreditation.

Payors:

Azina streamlined and showcased key performance data for payors with gateway requirements for specialty pharmacies. This forged an effective and productive relationship with one of the largest PBM payors in the industry. In turn, this new relationship facilitated access to an expanded base of approved and covered scripts enhancing patient access, improving patient satisfaction, and strengthening the overall performance of the specialty pharmacy.

The Results

As a result of the partnership with Azina, this large health system successfully increased oncology medication prescription volumes, grew revenue, and improved gross margin. The quantifiable results speak for themselves:

• Average daily revenue increased from $90K to $249K

• Average daily gross margins grew from $41K to $101K
• Monthly prescription volumes increased from 450 to 731
  

Pharma Access Results (WITH ACCESS TO COVETED ONCOLOGY DRUGS, THIS BECAME THE LEADING DISEASE STATE FOR REVENUE AND GROSS MARGIN) In just one year:

• Monthly script volume increased nearly 140%
• Monthly revenue increased 137%
• Gross margin increased over 200%
  

Payor Access Results (BY TAPPING INTO THE MAJOR NATIONAL PAYOR CHANNEL)

• 600+ new prescriptions have been generated
• $165M in revenue
• $7.9M in gross margin
  

Patient Satisfaction Results

• Patient satisfaction scores rose to 95%
• MPR at 6%
  

The Azina team is continuously planning next steps for our clients, focusing on transformational solutions that will lower overall costs, generate higher revenues, and improve patient satisfaction.

Contact Azina today!